These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3132968)
1. Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives. Badet B; Vermoote P; Le Goffic F Biochemistry; 1988 Apr; 27(7):2282-7. PubMed ID: 3132968 [TBL] [Abstract][Full Text] [Related]
2. Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives. Kucharczyk N; Denisot MA; Le Goffic F; Badet B Biochemistry; 1990 Apr; 29(15):3668-76. PubMed ID: 2111163 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs. Chmara H; Andruszkiewicz R; Borowski E Biochim Biophys Acta; 1986 Mar; 870(2):357-66. PubMed ID: 3082365 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase. Andruszkiewicz R; Chmara H; Milewski S; Borowski E Int J Pept Protein Res; 1986 May; 27(5):449-53. PubMed ID: 3089958 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT 2 SL 1027 by N beta-fumarylcarboxyamido-L-2,3-diamino-propionic acid. Chmara H; Andruszkiewicz R; Borowski E Biochem Biophys Res Commun; 1984 May; 120(3):865-72. PubMed ID: 6428401 [TBL] [Abstract][Full Text] [Related]
7. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides. Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933 [TBL] [Abstract][Full Text] [Related]
8. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase. Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235 [TBL] [Abstract][Full Text] [Related]
9. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase. Zgódka D; Jedrzejczak R; Milewski S; Borowski E Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the inhibition pathway of glucosamine synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid by semiempirical quantum mechanical and molecular mechanics methods. Tarnowska M; Oldziej S; Liwo A; Grzonka Z; Borowski E Eur Biophys J; 1992; 21(4):273-80. PubMed ID: 1425480 [TBL] [Abstract][Full Text] [Related]
11. Glucosamine synthetase from Escherichia coli: purification, properties, and glutamine-utilizing site location. Badet B; Vermoote P; Haumont PY; Lederer F; LeGoffic F Biochemistry; 1987 Apr; 26(7):1940-8. PubMed ID: 3297136 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase. Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131 [TBL] [Abstract][Full Text] [Related]
13. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design. Wojciechowski M; Milewski S; Mazerski J; Borowski E Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410 [TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. Milewski S; Mignini F; Covelli I; Borowski E J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase. Milewski S; Andruszkiewicz R; Kasprzak L; Mazerski J; Mignini F; Borowski E Antimicrob Agents Chemother; 1991 Jan; 35(1):36-43. PubMed ID: 1901701 [TBL] [Abstract][Full Text] [Related]
16. Anticapsin, an active-site directed irreversible inhibitor of glucosamine-6-phosphate synthetase from Escherichia coli. Chmara H; Zähner H; Borowski E J Antibiot (Tokyo); 1984 Sep; 37(9):1038-43. PubMed ID: 6389459 [TBL] [Abstract][Full Text] [Related]
17. Anticapsin: an active site directed inhibitor of glucosamine-6-phosphate synthetase from Candida albicans. Milewski S; Chmara H; Borowski E Drugs Exp Clin Res; 1986; 12(6-7):577-83. PubMed ID: 3527630 [TBL] [Abstract][Full Text] [Related]
18. Chemical modification studies of the active site of glucosamine-6-phosphate synthase from baker's yeast. Milewski S Biochim Biophys Acta; 1993 Feb; 1161(2-3):279-84. PubMed ID: 8431477 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucosamine synthase by bacilysin and anticapsin. Chmara H J Gen Microbiol; 1985 Feb; 131(2):265-71. PubMed ID: 3884731 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Escherichia coli glucosamine synthetase by novel electrophilic analogues of glutamine--comparison with 6-diazo-5-oxo-norleucine. Walker B; Brown MF; Lynas JF; Martin SL; McDowell A; Badet B; Hill AJ Bioorg Med Chem Lett; 2000 Dec; 10(24):2795-8. PubMed ID: 11133094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]